The fact that inflammatory licensed MSCs did not have any deleterious effect on chondrocytes, and maintained beneficial anti-inflammatory effects on IL-1β-stimulated chondrocytes, supports the investigation of inflammatory licensed MSCs for clinical use in diseases, such as arthritis. The gene discussed is IL1B; the disease is Arthritis.